Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Crohn Disease | 40 | 2022 | 2303 | 2.830 |
Why?
|
Gastroesophageal Reflux | 20 | 2022 | 782 | 2.520 |
Why?
|
Colitis, Ulcerative | 28 | 2022 | 1912 | 2.500 |
Why?
|
Inflammatory Bowel Diseases | 27 | 2021 | 2425 | 2.300 |
Why?
|
Proton Pump Inhibitors | 7 | 2015 | 526 | 1.690 |
Why?
|
Intestinal Mucosa | 19 | 2019 | 3036 | 1.160 |
Why?
|
Mesalamine | 3 | 2018 | 136 | 1.100 |
Why?
|
Gastroenterology | 10 | 2019 | 536 | 1.060 |
Why?
|
Pediatrics | 13 | 2019 | 3475 | 0.900 |
Why?
|
Gastrointestinal Diseases | 10 | 2019 | 1170 | 0.860 |
Why?
|
2-Pyridinylmethylsulfinylbenzimidazoles | 4 | 2010 | 35 | 0.730 |
Why?
|
Colon | 10 | 2018 | 1772 | 0.690 |
Why?
|
Child | 111 | 2022 | 77709 | 0.670 |
Why?
|
Feces | 8 | 2021 | 1401 | 0.670 |
Why?
|
Gastrointestinal Contents | 1 | 2018 | 34 | 0.660 |
Why?
|
Fungi | 3 | 2019 | 327 | 0.650 |
Why?
|
Autistic Disorder | 6 | 2022 | 1185 | 0.640 |
Why?
|
Drug Substitution | 1 | 2021 | 281 | 0.630 |
Why?
|
Sialyltransferases | 1 | 2018 | 75 | 0.620 |
Why?
|
Constipation | 3 | 2013 | 546 | 0.600 |
Why?
|
Proctocolectomy, Restorative | 5 | 2022 | 189 | 0.580 |
Why?
|
Probiotics | 1 | 2020 | 351 | 0.550 |
Why?
|
Diarrhea | 6 | 2021 | 1348 | 0.540 |
Why?
|
Intestine, Small | 6 | 2017 | 1241 | 0.510 |
Why?
|
Anti-Inflammatory Agents | 9 | 2017 | 1790 | 0.500 |
Why?
|
Child Development Disorders, Pervasive | 2 | 2010 | 615 | 0.490 |
Why?
|
Gastrointestinal Agents | 7 | 2017 | 494 | 0.490 |
Why?
|
C-Reactive Protein | 3 | 2018 | 3778 | 0.480 |
Why?
|
Serotonin 5-HT4 Receptor Agonists | 1 | 2013 | 11 | 0.470 |
Why?
|
Gastrointestinal Tract | 4 | 2019 | 814 | 0.460 |
Why?
|
Infant | 61 | 2018 | 35136 | 0.450 |
Why?
|
Laxatives | 1 | 2013 | 87 | 0.440 |
Why?
|
Benzofurans | 1 | 2013 | 140 | 0.440 |
Why?
|
Lymphoma | 2 | 2021 | 1877 | 0.430 |
Why?
|
Colonoscopy | 3 | 2017 | 1367 | 0.430 |
Why?
|
Transplantation | 1 | 2014 | 217 | 0.420 |
Why?
|
Intestines | 9 | 2011 | 1924 | 0.410 |
Why?
|
Defecation | 1 | 2013 | 188 | 0.410 |
Why?
|
Tuberculosis, Gastrointestinal | 1 | 2011 | 20 | 0.410 |
Why?
|
Adolescent | 78 | 2021 | 85781 | 0.410 |
Why?
|
Gastrostomy | 1 | 2014 | 309 | 0.390 |
Why?
|
Health Records, Personal | 1 | 2012 | 124 | 0.390 |
Why?
|
Diagnostic Errors | 1 | 2018 | 1257 | 0.390 |
Why?
|
Humans | 184 | 2022 | 744343 | 0.380 |
Why?
|
Granuloma | 2 | 2012 | 319 | 0.380 |
Why?
|
Peritoneum | 1 | 2011 | 228 | 0.370 |
Why?
|
Biopsy | 10 | 2019 | 6756 | 0.370 |
Why?
|
Child, Preschool | 58 | 2021 | 41006 | 0.360 |
Why?
|
Cecum | 2 | 2010 | 237 | 0.360 |
Why?
|
Cecal Diseases | 1 | 2010 | 51 | 0.360 |
Why?
|
Research Report | 2 | 2012 | 355 | 0.360 |
Why?
|
Anti-Ulcer Agents | 3 | 2007 | 119 | 0.350 |
Why?
|
Peritonitis | 1 | 2011 | 365 | 0.340 |
Why?
|
Antibodies, Monoclonal | 10 | 2014 | 9274 | 0.340 |
Why?
|
Metagenome | 1 | 2012 | 418 | 0.340 |
Why?
|
Male | 103 | 2022 | 350118 | 0.340 |
Why?
|
Appendix | 1 | 2010 | 110 | 0.330 |
Why?
|
Congresses as Topic | 2 | 2018 | 764 | 0.330 |
Why?
|
Child Welfare | 2 | 2012 | 523 | 0.330 |
Why?
|
Intussusception | 1 | 2010 | 115 | 0.330 |
Why?
|
Child Nutrition Disorders | 3 | 2010 | 149 | 0.330 |
Why?
|
Health Surveys | 1 | 2019 | 4037 | 0.320 |
Why?
|
Abdominal Pain | 4 | 2011 | 1063 | 0.320 |
Why?
|
Anal Canal | 4 | 2016 | 376 | 0.310 |
Why?
|
Colectomy | 5 | 2021 | 683 | 0.310 |
Why?
|
Lymph Node Excision | 1 | 2014 | 1261 | 0.310 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2014 | 2282 | 0.310 |
Why?
|
Infant Formula | 1 | 2009 | 199 | 0.310 |
Why?
|
Colitis | 5 | 2019 | 1170 | 0.310 |
Why?
|
Female | 102 | 2022 | 380194 | 0.310 |
Why?
|
Duodenum | 3 | 2017 | 483 | 0.300 |
Why?
|
Melanoma, Experimental | 3 | 2001 | 561 | 0.300 |
Why?
|
Clostridium Infections | 1 | 2014 | 548 | 0.300 |
Why?
|
Double-Blind Method | 10 | 2015 | 12026 | 0.290 |
Why?
|
Intestinal Obstruction | 2 | 2010 | 424 | 0.290 |
Why?
|
Acquired Immunodeficiency Syndrome | 7 | 1996 | 2232 | 0.280 |
Why?
|
Societies, Medical | 9 | 2018 | 3743 | 0.270 |
Why?
|
Anti-Bacterial Agents | 4 | 2020 | 7181 | 0.270 |
Why?
|
Omeprazole | 2 | 2003 | 112 | 0.270 |
Why?
|
North America | 8 | 2019 | 1249 | 0.270 |
Why?
|
Diacylglycerol O-Acyltransferase | 2 | 2017 | 22 | 0.260 |
Why?
|
Fellowships and Scholarships | 1 | 2014 | 1076 | 0.260 |
Why?
|
Cooperative Behavior | 1 | 2012 | 1504 | 0.250 |
Why?
|
Endoscopy | 2 | 2019 | 1785 | 0.250 |
Why?
|
Occult Blood | 2 | 2016 | 176 | 0.250 |
Why?
|
Rectal Neoplasms | 1 | 2014 | 1206 | 0.250 |
Why?
|
Gastric Acid | 2 | 2003 | 104 | 0.240 |
Why?
|
Awards and Prizes | 1 | 2009 | 375 | 0.240 |
Why?
|
Stomatitis, Aphthous | 2 | 2009 | 53 | 0.230 |
Why?
|
Interleukin-10 Receptor alpha Subunit | 2 | 2021 | 27 | 0.230 |
Why?
|
Bacterial Typing Techniques | 2 | 2016 | 256 | 0.230 |
Why?
|
Physical Examination | 3 | 2016 | 1237 | 0.230 |
Why?
|
Saudi Arabia | 3 | 2021 | 209 | 0.230 |
Why?
|
Nutritional Physiological Phenomena | 3 | 2002 | 370 | 0.230 |
Why?
|
Malabsorption Syndromes | 4 | 2002 | 135 | 0.230 |
Why?
|
Enteric Nervous System | 1 | 2006 | 189 | 0.220 |
Why?
|
Callitrichinae | 3 | 1989 | 23 | 0.220 |
Why?
|
Esophagitis | 5 | 2007 | 152 | 0.220 |
Why?
|
Genetic Variation | 1 | 2018 | 6544 | 0.220 |
Why?
|
Failure to Thrive | 2 | 2021 | 136 | 0.220 |
Why?
|
Lung Neoplasms | 7 | 2021 | 13102 | 0.220 |
Why?
|
Lymph Nodes | 5 | 2021 | 3474 | 0.210 |
Why?
|
Age of Onset | 5 | 2021 | 3271 | 0.210 |
Why?
|
Immunologic Deficiency Syndromes | 3 | 2015 | 547 | 0.210 |
Why?
|
Colonic Neoplasms | 1 | 2014 | 2541 | 0.210 |
Why?
|
Weight Gain | 3 | 2009 | 2292 | 0.210 |
Why?
|
Child Nutrition Sciences | 2 | 2018 | 23 | 0.210 |
Why?
|
Tumor Necrosis Factor-alpha | 5 | 2021 | 4420 | 0.200 |
Why?
|
Energy Intake | 1 | 2009 | 2148 | 0.200 |
Why?
|
Colonic Pouches | 1 | 2022 | 121 | 0.190 |
Why?
|
Cystic Fibrosis | 1 | 2010 | 1177 | 0.190 |
Why?
|
Infant, Newborn | 28 | 2015 | 25625 | 0.190 |
Why?
|
Rectal Fistula | 1 | 2021 | 73 | 0.190 |
Why?
|
Food Hypersensitivity | 3 | 2010 | 622 | 0.190 |
Why?
|
Secondary Prevention | 2 | 2017 | 1530 | 0.190 |
Why?
|
Adoptive Transfer | 2 | 2000 | 844 | 0.180 |
Why?
|
Treatment Outcome | 21 | 2021 | 63114 | 0.180 |
Why?
|
Nerve Regeneration | 1 | 2006 | 788 | 0.180 |
Why?
|
Allergy and Immunology | 1 | 2002 | 169 | 0.180 |
Why?
|
Pouchitis | 1 | 2020 | 62 | 0.180 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11524 | 0.180 |
Why?
|
Adolescent Health Services | 1 | 2002 | 215 | 0.180 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2022 | 15519 | 0.180 |
Why?
|
Cancer Vaccines | 4 | 2001 | 1023 | 0.170 |
Why?
|
Digestive System | 2 | 1999 | 253 | 0.170 |
Why?
|
Child Nutritional Physiological Phenomena | 4 | 2008 | 303 | 0.170 |
Why?
|
Esophagitis, Peptic | 3 | 2011 | 78 | 0.160 |
Why?
|
Gastrointestinal Motility | 3 | 2013 | 225 | 0.160 |
Why?
|
Nutritional Support | 2 | 1998 | 168 | 0.160 |
Why?
|
Delivery of Health Care | 2 | 2016 | 5319 | 0.160 |
Why?
|
Fetus | 3 | 1999 | 1880 | 0.160 |
Why?
|
Case-Control Studies | 12 | 2018 | 21746 | 0.160 |
Why?
|
Gastroenteritis | 2 | 2012 | 245 | 0.160 |
Why?
|
Erythema Nodosum | 1 | 1998 | 30 | 0.160 |
Why?
|
Severity of Illness Index | 13 | 2019 | 15540 | 0.160 |
Why?
|
Clinical Competence | 1 | 2014 | 4687 | 0.160 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 3 | 2021 | 5221 | 0.160 |
Why?
|
Research | 4 | 2016 | 1999 | 0.160 |
Why?
|
Biological Transport, Active | 1 | 2018 | 349 | 0.150 |
Why?
|
Dietary Proteins | 2 | 2002 | 963 | 0.150 |
Why?
|
Risk Reduction Behavior | 1 | 2004 | 1125 | 0.150 |
Why?
|
Pancreas | 3 | 2010 | 1686 | 0.150 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2009 | 2026 | 0.150 |
Why?
|
Remission Induction | 5 | 2014 | 2386 | 0.150 |
Why?
|
Biomedical Research | 2 | 2012 | 3309 | 0.150 |
Why?
|
B-Lymphocytes | 6 | 2013 | 4665 | 0.150 |
Why?
|
Interferon-gamma | 2 | 2008 | 3206 | 0.150 |
Why?
|
Neuronal Plasticity | 1 | 2006 | 1422 | 0.150 |
Why?
|
Celiac Disease | 3 | 2014 | 785 | 0.150 |
Why?
|
Databases, Factual | 1 | 2012 | 7729 | 0.150 |
Why?
|
Pyoderma Gangrenosum | 1 | 1998 | 76 | 0.140 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2009 | 2104 | 0.140 |
Why?
|
Hair Diseases | 1 | 1997 | 74 | 0.140 |
Why?
|
Chemokine CCL11 | 2 | 2014 | 129 | 0.140 |
Why?
|
Dietary Carbohydrates | 1 | 2002 | 906 | 0.140 |
Why?
|
T-Lymphocytes, Cytotoxic | 3 | 2001 | 1821 | 0.140 |
Why?
|
Duodenoscopy | 1 | 2016 | 52 | 0.140 |
Why?
|
Peptide Hydrolases | 1 | 1999 | 634 | 0.140 |
Why?
|
Administration, Oral | 5 | 2013 | 3913 | 0.140 |
Why?
|
Young Adult | 12 | 2021 | 56430 | 0.140 |
Why?
|
Leukocyte L1 Antigen Complex | 1 | 2016 | 88 | 0.140 |
Why?
|
Immunosuppressive Agents | 5 | 2021 | 4149 | 0.140 |
Why?
|
Keratins | 1 | 1997 | 515 | 0.130 |
Why?
|
HIV Infections | 6 | 2009 | 16718 | 0.130 |
Why?
|
Nutrition Disorders | 3 | 1998 | 211 | 0.130 |
Why?
|
Lactoferrin | 1 | 2016 | 97 | 0.130 |
Why?
|
Chemokine CXCL5 | 1 | 2015 | 27 | 0.130 |
Why?
|
Intestinal Diseases | 4 | 2006 | 530 | 0.130 |
Why?
|
Herpesvirus 4, Human | 1 | 2021 | 1041 | 0.130 |
Why?
|
Nervous System Diseases | 1 | 2006 | 1622 | 0.130 |
Why?
|
Saguinus | 2 | 1985 | 17 | 0.130 |
Why?
|
Enzyme Inhibitors | 2 | 2003 | 3798 | 0.130 |
Why?
|
HIV-1 | 5 | 1994 | 6939 | 0.130 |
Why?
|
Inflammation | 3 | 2021 | 10638 | 0.130 |
Why?
|
Endoscopy, Gastrointestinal | 2 | 2018 | 868 | 0.120 |
Why?
|
Glucocorticoids | 2 | 2019 | 2107 | 0.120 |
Why?
|
Carbohydrate Metabolism | 2 | 2017 | 264 | 0.120 |
Why?
|
Lactose Intolerance | 2 | 2011 | 27 | 0.120 |
Why?
|
Continuity of Patient Care | 1 | 2002 | 1049 | 0.120 |
Why?
|
Autoantibodies | 2 | 1994 | 2035 | 0.120 |
Why?
|
Adult | 38 | 2019 | 214055 | 0.120 |
Why?
|
Esophagus | 6 | 1994 | 1019 | 0.120 |
Why?
|
Rectum | 4 | 1994 | 904 | 0.120 |
Why?
|
Fetal Tissue Transplantation | 2 | 1992 | 139 | 0.120 |
Why?
|
Eosinophils | 2 | 2013 | 955 | 0.120 |
Why?
|
Esophagoscopy | 4 | 2006 | 390 | 0.120 |
Why?
|
Serum Albumin | 3 | 2012 | 676 | 0.120 |
Why?
|
Area Under Curve | 4 | 2013 | 1654 | 0.120 |
Why?
|
Matched-Pair Analysis | 1 | 2014 | 288 | 0.110 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2016 | 3870 | 0.110 |
Why?
|
Interleukins | 1 | 1998 | 791 | 0.110 |
Why?
|
Phylogeny | 2 | 2019 | 2803 | 0.110 |
Why?
|
Retrospective Studies | 20 | 2022 | 77449 | 0.110 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 1 | 2017 | 260 | 0.110 |
Why?
|
Intubation, Gastrointestinal | 1 | 2014 | 152 | 0.110 |
Why?
|
Ribosome Subunits, Small | 1 | 2012 | 5 | 0.110 |
Why?
|
Tablets | 1 | 2013 | 145 | 0.110 |
Why?
|
Europe | 5 | 2019 | 3339 | 0.110 |
Why?
|
Quality of Life | 5 | 2021 | 12804 | 0.110 |
Why?
|
Gastritis | 1 | 2014 | 196 | 0.110 |
Why?
|
Colon, Transverse | 1 | 2012 | 23 | 0.110 |
Why?
|
Stress, Psychological | 1 | 2008 | 4245 | 0.110 |
Why?
|
Domperidone | 1 | 1992 | 23 | 0.110 |
Why?
|
Immune System | 1 | 1998 | 805 | 0.110 |
Why?
|
Immunotherapy, Adoptive | 1 | 2001 | 1270 | 0.110 |
Why?
|
Recurrence | 6 | 2017 | 8340 | 0.110 |
Why?
|
Diarrhea, Infantile | 1 | 2012 | 109 | 0.110 |
Why?
|
PTEN Phosphohydrolase | 1 | 2018 | 1142 | 0.110 |
Why?
|
Blood Sedimentation | 2 | 2010 | 231 | 0.110 |
Why?
|
Abscess | 1 | 2016 | 607 | 0.100 |
Why?
|
Image Enhancement | 2 | 2019 | 2921 | 0.100 |
Why?
|
Growth | 2 | 1993 | 376 | 0.100 |
Why?
|
Mutation, Missense | 2 | 2021 | 2564 | 0.100 |
Why?
|
Hypoalbuminemia | 1 | 2012 | 87 | 0.100 |
Why?
|
Lymphatic Metastasis | 3 | 2019 | 2924 | 0.100 |
Why?
|
Interprofessional Relations | 1 | 2018 | 1011 | 0.100 |
Why?
|
Sucrase | 1 | 2011 | 54 | 0.100 |
Why?
|
Drainage | 2 | 2016 | 1142 | 0.100 |
Why?
|
Gastric Mucosa | 1 | 2014 | 599 | 0.100 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 1995 | 657 | 0.100 |
Why?
|
Papilloma | 1 | 1992 | 148 | 0.100 |
Why?
|
Immunologic Factors | 3 | 2010 | 1580 | 0.100 |
Why?
|
alpha-Glucosidases | 1 | 2011 | 44 | 0.100 |
Why?
|
Immunity, Mucosal | 2 | 2014 | 490 | 0.100 |
Why?
|
Delayed-Action Preparations | 1 | 2014 | 968 | 0.100 |
Why?
|
Lactase | 1 | 2011 | 69 | 0.100 |
Why?
|
Tuberculin Test | 1 | 2011 | 214 | 0.090 |
Why?
|
Fecal Incontinence | 1 | 2013 | 239 | 0.090 |
Why?
|
Carnitine | 1 | 1992 | 246 | 0.090 |
Why?
|
Esophageal Atresia | 3 | 1989 | 201 | 0.090 |
Why?
|
Dosage Forms | 1 | 2010 | 56 | 0.090 |
Why?
|
Weight Loss | 2 | 2012 | 2622 | 0.090 |
Why?
|
Receptors, Lymphocyte Homing | 1 | 2010 | 143 | 0.090 |
Why?
|
Statistics as Topic | 1 | 2017 | 2373 | 0.090 |
Why?
|
Stomach | 2 | 2014 | 697 | 0.090 |
Why?
|
False Negative Reactions | 1 | 2011 | 588 | 0.090 |
Why?
|
Gastric Acidity Determination | 3 | 2004 | 62 | 0.090 |
Why?
|
Child Health Services | 1 | 2016 | 667 | 0.090 |
Why?
|
Proportional Hazards Models | 3 | 2015 | 12354 | 0.090 |
Why?
|
Glomerulonephritis, Membranous | 1 | 1991 | 86 | 0.090 |
Why?
|
Sulfasalazine | 2 | 1993 | 79 | 0.090 |
Why?
|
Animals | 25 | 2020 | 168757 | 0.090 |
Why?
|
Digestion | 2 | 2017 | 54 | 0.090 |
Why?
|
Cytotoxicity, Immunologic | 5 | 2001 | 1369 | 0.090 |
Why?
|
Breath Tests | 2 | 1991 | 280 | 0.090 |
Why?
|
Bone and Bones | 1 | 2021 | 2575 | 0.090 |
Why?
|
Bahamas | 1 | 2009 | 11 | 0.090 |
Why?
|
Proctocolitis | 1 | 1990 | 25 | 0.090 |
Why?
|
Cytoplasm | 1 | 1994 | 1539 | 0.090 |
Why?
|
Adrenal Cortex Hormones | 4 | 2014 | 1855 | 0.090 |
Why?
|
Th2 Cells | 2 | 2008 | 1061 | 0.090 |
Why?
|
Diagnostic Techniques, Digestive System | 1 | 2010 | 47 | 0.090 |
Why?
|
Caseins | 1 | 2010 | 104 | 0.090 |
Why?
|
Diet, Protein-Restricted | 1 | 2010 | 71 | 0.090 |
Why?
|
Hydrogen-Ion Concentration | 4 | 2022 | 2557 | 0.090 |
Why?
|
Flagellin | 1 | 2010 | 125 | 0.090 |
Why?
|
Perioperative Care | 1 | 2017 | 1002 | 0.090 |
Why?
|
Health Priorities | 1 | 2012 | 380 | 0.090 |
Why?
|
Pancreas Transplantation | 1 | 2010 | 187 | 0.090 |
Why?
|
Aminosalicylic Acids | 3 | 2014 | 37 | 0.090 |
Why?
|
Immunoglobulin A | 2 | 2010 | 992 | 0.090 |
Why?
|
Th1 Cells | 2 | 2008 | 1057 | 0.080 |
Why?
|
Medical Informatics | 1 | 2016 | 745 | 0.080 |
Why?
|
STAT3 Transcription Factor | 1 | 2013 | 873 | 0.080 |
Why?
|
Cytokines | 5 | 2013 | 7322 | 0.080 |
Why?
|
Injections, Subcutaneous | 2 | 2001 | 666 | 0.080 |
Why?
|
Liver Diseases | 4 | 2010 | 1253 | 0.080 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2012 | 954 | 0.080 |
Why?
|
Middle Aged | 22 | 2019 | 213383 | 0.080 |
Why?
|
Follow-Up Studies | 11 | 2021 | 39050 | 0.080 |
Why?
|
Enteritis | 2 | 1990 | 165 | 0.080 |
Why?
|
Prospective Studies | 9 | 2018 | 53288 | 0.080 |
Why?
|
Membrane Glycoproteins | 1 | 1999 | 3768 | 0.080 |
Why?
|
Time Factors | 16 | 2017 | 40075 | 0.080 |
Why?
|
Autoimmune Diseases | 2 | 1991 | 2133 | 0.080 |
Why?
|
Toll-Like Receptor 2 | 1 | 2010 | 354 | 0.080 |
Why?
|
Enteral Nutrition | 1 | 2014 | 763 | 0.080 |
Why?
|
Practice Guidelines as Topic | 3 | 2019 | 7279 | 0.080 |
Why?
|
History, 21st Century | 2 | 2018 | 1534 | 0.080 |
Why?
|
Software | 2 | 2016 | 4443 | 0.080 |
Why?
|
Folic Acid Deficiency | 1 | 2008 | 115 | 0.080 |
Why?
|
Serologic Tests | 1 | 2010 | 374 | 0.080 |
Why?
|
MicroRNAs | 2 | 2015 | 3752 | 0.080 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2010 | 288 | 0.080 |
Why?
|
Transplantation, Heterologous | 3 | 1992 | 2382 | 0.080 |
Why?
|
Receptors, Growth Factor | 1 | 2009 | 334 | 0.080 |
Why?
|
Biological Products | 1 | 2017 | 860 | 0.080 |
Why?
|
Esophageal Stenosis | 2 | 1987 | 195 | 0.080 |
Why?
|
Permeability | 1 | 2010 | 738 | 0.080 |
Why?
|
Pyloric Stenosis | 1 | 1987 | 29 | 0.080 |
Why?
|
Chi-Square Distribution | 2 | 2012 | 3508 | 0.080 |
Why?
|
Interleukin-10 | 3 | 2021 | 1200 | 0.080 |
Why?
|
Residence Characteristics | 1 | 2017 | 2050 | 0.080 |
Why?
|
DNA, Bacterial | 1 | 2012 | 1465 | 0.070 |
Why?
|
Aged, 80 and over | 8 | 2019 | 57776 | 0.070 |
Why?
|
Vitamin D | 1 | 2021 | 3223 | 0.070 |
Why?
|
Immunoglobulin G | 3 | 2014 | 4560 | 0.070 |
Why?
|
Diet, Gluten-Free | 1 | 2010 | 271 | 0.070 |
Why?
|
Agammaglobulinemia | 2 | 1985 | 167 | 0.070 |
Why?
|
Surgical Staplers | 1 | 2006 | 34 | 0.070 |
Why?
|
Zenker Diverticulum | 1 | 2006 | 20 | 0.070 |
Why?
|
Life Style | 1 | 1999 | 3835 | 0.070 |
Why?
|
Histocompatibility Antigens Class II | 2 | 2000 | 1475 | 0.070 |
Why?
|
Growth Disorders | 2 | 2008 | 645 | 0.070 |
Why?
|
Milk | 2 | 2009 | 450 | 0.070 |
Why?
|
Prednisone | 3 | 1991 | 1574 | 0.070 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2010 | 903 | 0.070 |
Why?
|
Lymphocyte Activation | 6 | 2001 | 5524 | 0.070 |
Why?
|
Bile Duct Neoplasms | 1 | 1992 | 567 | 0.070 |
Why?
|
Digestive System Physiological Phenomena | 1 | 2006 | 16 | 0.070 |
Why?
|
Prognosis | 5 | 2019 | 29063 | 0.070 |
Why?
|
Nutrition Assessment | 1 | 2010 | 723 | 0.070 |
Why?
|
Radiography, Abdominal | 1 | 2010 | 537 | 0.070 |
Why?
|
Nifedipine | 1 | 1986 | 226 | 0.070 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2019 | 3327 | 0.070 |
Why?
|
Mitochondrial Diseases | 1 | 2010 | 320 | 0.070 |
Why?
|
Survival Rate | 3 | 2019 | 12788 | 0.070 |
Why?
|
Leukocytes, Mononuclear | 1 | 2013 | 1836 | 0.070 |
Why?
|
Body Composition | 2 | 2008 | 2401 | 0.070 |
Why?
|
Medical History Taking | 1 | 2010 | 783 | 0.070 |
Why?
|
Collagen | 1 | 2014 | 2689 | 0.070 |
Why?
|
Tracheoesophageal Fistula | 1 | 1987 | 129 | 0.070 |
Why?
|
Sex Distribution | 2 | 2017 | 2297 | 0.070 |
Why?
|
Contrast Media | 1 | 2019 | 5300 | 0.070 |
Why?
|
Postoperative Complications | 8 | 2022 | 15295 | 0.070 |
Why?
|
Withholding Treatment | 1 | 2010 | 599 | 0.070 |
Why?
|
Esophageal Achalasia | 1 | 1986 | 91 | 0.070 |
Why?
|
Growth Hormone | 1 | 2008 | 705 | 0.070 |
Why?
|
Diagnosis, Differential | 3 | 2011 | 12959 | 0.070 |
Why?
|
Genotype | 2 | 2018 | 12951 | 0.070 |
Why?
|
Epithelium | 5 | 1992 | 1679 | 0.070 |
Why?
|
Peritoneal Neoplasms | 1 | 2011 | 665 | 0.070 |
Why?
|
Disease Models, Animal | 5 | 2018 | 18029 | 0.070 |
Why?
|
Social Adjustment | 1 | 2008 | 631 | 0.060 |
Why?
|
Autoantigens | 1 | 1989 | 892 | 0.060 |
Why?
|
Factor Analysis, Statistical | 1 | 2008 | 977 | 0.060 |
Why?
|
Age Distribution | 2 | 2017 | 2902 | 0.060 |
Why?
|
Brazil | 1 | 2009 | 1270 | 0.060 |
Why?
|
HIV | 1 | 1992 | 1604 | 0.060 |
Why?
|
Parents | 1 | 2019 | 3407 | 0.060 |
Why?
|
Histamine H1 Antagonists | 1 | 2005 | 100 | 0.060 |
Why?
|
Organometallic Compounds | 2 | 2019 | 665 | 0.060 |
Why?
|
Cysts | 1 | 2010 | 678 | 0.060 |
Why?
|
Adenomatous Polyposis Coli | 2 | 1999 | 224 | 0.060 |
Why?
|
Child Behavior Disorders | 1 | 2010 | 807 | 0.060 |
Why?
|
Digestive System Surgical Procedures | 2 | 2010 | 576 | 0.060 |
Why?
|
Dilatation | 1 | 1986 | 291 | 0.060 |
Why?
|
Nizatidine | 1 | 2004 | 7 | 0.060 |
Why?
|
Neoplasm Staging | 3 | 2019 | 11031 | 0.060 |
Why?
|
Aged | 14 | 2019 | 163280 | 0.060 |
Why?
|
Drug Administration Schedule | 2 | 2010 | 4933 | 0.060 |
Why?
|
Irritable Bowel Syndrome | 1 | 2010 | 445 | 0.060 |
Why?
|
Esophagoplasty | 1 | 1984 | 43 | 0.060 |
Why?
|
Premedication | 1 | 2005 | 258 | 0.060 |
Why?
|
Sulfoxides | 1 | 2003 | 48 | 0.060 |
Why?
|
Age Factors | 8 | 2011 | 18370 | 0.060 |
Why?
|
Esophageal Fistula | 1 | 1984 | 64 | 0.060 |
Why?
|
Bronchial Fistula | 1 | 1984 | 85 | 0.060 |
Why?
|
Mice, Inbred C57BL | 6 | 2018 | 21827 | 0.060 |
Why?
|
Chronic Disease | 2 | 2010 | 9146 | 0.060 |
Why?
|
Manometry | 4 | 2006 | 445 | 0.060 |
Why?
|
Islets of Langerhans | 1 | 2010 | 1352 | 0.060 |
Why?
|
Cells, Cultured | 5 | 2013 | 19229 | 0.060 |
Why?
|
Reperfusion Injury | 1 | 2010 | 1026 | 0.060 |
Why?
|
Arthritis | 1 | 2009 | 659 | 0.060 |
Why?
|
Incidence | 7 | 2018 | 20947 | 0.060 |
Why?
|
DNA Methylation | 2 | 2014 | 4286 | 0.060 |
Why?
|
Genetic Testing | 2 | 2021 | 3444 | 0.060 |
Why?
|
Aging | 2 | 2015 | 8664 | 0.060 |
Why?
|
Patient Care Team | 2 | 2010 | 2531 | 0.060 |
Why?
|
Chemoprevention | 1 | 2005 | 319 | 0.060 |
Why?
|
Health Education | 1 | 2010 | 1056 | 0.060 |
Why?
|
Body Image | 1 | 2008 | 610 | 0.050 |
Why?
|
Alleles | 2 | 2017 | 6933 | 0.050 |
Why?
|
Epitopes | 1 | 1989 | 2571 | 0.050 |
Why?
|
Histamine H2 Antagonists | 1 | 2004 | 165 | 0.050 |
Why?
|
Hybrid Cells | 2 | 2000 | 441 | 0.050 |
Why?
|
Eosinophilia | 1 | 1987 | 541 | 0.050 |
Why?
|
Injections, Intravenous | 2 | 2004 | 1420 | 0.050 |
Why?
|
Glycogen Storage Disease Type III | 2 | 1992 | 13 | 0.050 |
Why?
|
Databases, Genetic | 1 | 2010 | 1783 | 0.050 |
Why?
|
T-Lymphocytes | 5 | 2000 | 10180 | 0.050 |
Why?
|
Intestinal Absorption | 1 | 2003 | 420 | 0.050 |
Why?
|
alpha-Amylases | 1 | 2002 | 41 | 0.050 |
Why?
|
3' Untranslated Regions | 2 | 2015 | 513 | 0.050 |
Why?
|
Sensitivity and Specificity | 4 | 2010 | 14722 | 0.050 |
Why?
|
Neutrophils | 1 | 1994 | 3719 | 0.050 |
Why?
|
Folic Acid | 1 | 2008 | 1300 | 0.050 |
Why?
|
Cardiomyopathies | 2 | 1992 | 1912 | 0.050 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2005 | 365 | 0.050 |
Why?
|
Mutation | 2 | 2015 | 29786 | 0.050 |
Why?
|
Mice, Knockout | 4 | 2018 | 14557 | 0.050 |
Why?
|
Fabaceae | 1 | 2002 | 103 | 0.050 |
Why?
|
Mucins | 1 | 1985 | 564 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 1 | 2012 | 6538 | 0.050 |
Why?
|
England | 2 | 2001 | 522 | 0.050 |
Why?
|
Safety | 2 | 2003 | 1186 | 0.050 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2003 | 419 | 0.050 |
Why?
|
Esophageal pH Monitoring | 1 | 2022 | 191 | 0.050 |
Why?
|
Azathioprine | 2 | 2014 | 353 | 0.050 |
Why?
|
Abdomen | 1 | 1987 | 1118 | 0.050 |
Why?
|
Immune Sera | 1 | 2001 | 641 | 0.050 |
Why?
|
Neoplasms | 3 | 2017 | 21683 | 0.050 |
Why?
|
United States | 9 | 2009 | 69872 | 0.050 |
Why?
|
Lymphokines | 2 | 1983 | 949 | 0.050 |
Why?
|
Hypersensitivity | 1 | 1990 | 1102 | 0.050 |
Why?
|
Mice | 11 | 2018 | 81183 | 0.050 |
Why?
|
Mycobacterium tuberculosis | 1 | 2011 | 1832 | 0.050 |
Why?
|
Vitiligo | 1 | 2001 | 89 | 0.050 |
Why?
|
Genomics | 1 | 2016 | 5720 | 0.050 |
Why?
|
Mice, Inbred DBA | 1 | 2001 | 642 | 0.050 |
Why?
|
Trialkyltin Compounds | 1 | 1999 | 6 | 0.050 |
Why?
|
Postoperative Period | 1 | 2005 | 1842 | 0.050 |
Why?
|
Killer Cells, Lymphokine-Activated | 1 | 1999 | 42 | 0.050 |
Why?
|
Gene Expression Regulation | 3 | 2015 | 12072 | 0.050 |
Why?
|
Developing Countries | 1 | 2012 | 2815 | 0.050 |
Why?
|
Steroids | 2 | 1998 | 930 | 0.040 |
Why?
|
Risk Assessment | 6 | 2017 | 23338 | 0.040 |
Why?
|
Odds Ratio | 1 | 2012 | 9849 | 0.040 |
Why?
|
Geriatrics | 1 | 2004 | 396 | 0.040 |
Why?
|
Robotics | 1 | 2007 | 899 | 0.040 |
Why?
|
Carcinoma | 1 | 2011 | 2375 | 0.040 |
Why?
|
Registries | 5 | 2017 | 8089 | 0.040 |
Why?
|
Nucleic Acid Hybridization | 2 | 1992 | 1375 | 0.040 |
Why?
|
Emigration and Immigration | 2 | 2001 | 404 | 0.040 |
Why?
|
Plant Proteins | 1 | 2002 | 364 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 4 | 2022 | 17446 | 0.040 |
Why?
|
Pore Forming Cytotoxic Proteins | 1 | 1999 | 130 | 0.040 |
Why?
|
Immunophenotyping | 2 | 2001 | 1880 | 0.040 |
Why?
|
Tumor Cells, Cultured | 4 | 2001 | 6314 | 0.040 |
Why?
|
Germany | 2 | 2015 | 862 | 0.040 |
Why?
|
Perforin | 1 | 1999 | 168 | 0.040 |
Why?
|
Mice, Nude | 3 | 1992 | 3689 | 0.040 |
Why?
|
Asia, Southeastern | 1 | 1999 | 111 | 0.040 |
Why?
|
Fas Ligand Protein | 1 | 1999 | 216 | 0.040 |
Why?
|
Surgery, Computer-Assisted | 1 | 2007 | 1018 | 0.040 |
Why?
|
Meglumine | 1 | 2019 | 149 | 0.040 |
Why?
|
Nutritive Value | 1 | 2002 | 339 | 0.040 |
Why?
|
Radiation Protection | 1 | 2002 | 419 | 0.040 |
Why?
|
Chemotaxis | 2 | 2013 | 607 | 0.040 |
Why?
|
Digestive System Abnormalities | 1 | 1999 | 52 | 0.040 |
Why?
|
Subcellular Fractions | 1 | 1999 | 547 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2001 | 4479 | 0.040 |
Why?
|
Hydrolysis | 1 | 1999 | 682 | 0.040 |
Why?
|
Benzimidazoles | 1 | 2003 | 850 | 0.040 |
Why?
|
Mice, Inbred C3H | 1 | 1999 | 964 | 0.040 |
Why?
|
Infusions, Intravenous | 1 | 2003 | 2274 | 0.040 |
Why?
|
Gastric Emptying | 2 | 1992 | 233 | 0.040 |
Why?
|
Biliary Tract Diseases | 1 | 1999 | 161 | 0.040 |
Why?
|
Electron Transport Chain Complex Proteins | 1 | 2017 | 38 | 0.040 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2002 | 709 | 0.040 |
Why?
|
Disaccharidases | 1 | 2017 | 18 | 0.040 |
Why?
|
Ileum | 2 | 2010 | 565 | 0.040 |
Why?
|
Radiosurgery | 1 | 2007 | 1329 | 0.040 |
Why?
|
Constriction, Pathologic | 2 | 2010 | 1107 | 0.040 |
Why?
|
Echovirus Infections | 1 | 1977 | 7 | 0.040 |
Why?
|
Delayed Diagnosis | 1 | 2021 | 441 | 0.040 |
Why?
|
Cell Separation | 1 | 1983 | 1751 | 0.040 |
Why?
|
Melanoma | 3 | 2002 | 5510 | 0.040 |
Why?
|
Fertility | 1 | 2022 | 781 | 0.040 |
Why?
|
DNA, Fungal | 1 | 2018 | 280 | 0.040 |
Why?
|
Pedigree | 2 | 2012 | 4644 | 0.040 |
Why?
|
Competency-Based Education | 1 | 1999 | 211 | 0.040 |
Why?
|
Nitriles | 1 | 2022 | 956 | 0.040 |
Why?
|
Random Allocation | 1 | 2002 | 2429 | 0.040 |
Why?
|
Disease-Free Survival | 2 | 2005 | 6895 | 0.040 |
Why?
|
Heart | 1 | 1990 | 4467 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2004 | 10943 | 0.040 |
Why?
|
Drug Tolerance | 1 | 1998 | 376 | 0.040 |
Why?
|
Histone Deacetylases | 1 | 2021 | 728 | 0.040 |
Why?
|
Pancreatic Diseases | 1 | 1999 | 350 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 1 | 2009 | 4554 | 0.030 |
Why?
|
Drug Hypersensitivity | 1 | 2005 | 884 | 0.030 |
Why?
|
Health Personnel | 1 | 2010 | 3218 | 0.030 |
Why?
|
Health | 1 | 2019 | 394 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2021 | 1184 | 0.030 |
Why?
|
Algorithms | 3 | 2014 | 13881 | 0.030 |
Why?
|
Methotrexate | 2 | 2014 | 1727 | 0.030 |
Why?
|
Cohort Studies | 8 | 2013 | 40561 | 0.030 |
Why?
|
Lymphoproliferative Disorders | 1 | 1999 | 523 | 0.030 |
Why?
|
Glycogen Debranching Enzyme System | 2 | 1992 | 5 | 0.030 |
Why?
|
Biological Therapy | 1 | 2017 | 138 | 0.030 |
Why?
|
Gadolinium DTPA | 1 | 2019 | 836 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 1999 | 2085 | 0.030 |
Why?
|
Aotus trivirgatus | 2 | 1985 | 37 | 0.030 |
Why?
|
Faculty | 1 | 1999 | 386 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 1997 | 342 | 0.030 |
Why?
|
Viruses | 1 | 2019 | 374 | 0.030 |
Why?
|
Hepatomegaly | 1 | 1995 | 85 | 0.030 |
Why?
|
Anastomosis, Surgical | 2 | 2017 | 987 | 0.030 |
Why?
|
Guidelines as Topic | 1 | 2002 | 1405 | 0.030 |
Why?
|
Fluoroimmunoassay | 1 | 1994 | 33 | 0.030 |
Why?
|
Treatment Failure | 1 | 2021 | 2618 | 0.030 |
Why?
|
Gastrins | 1 | 2014 | 81 | 0.030 |
Why?
|
Callithrix | 2 | 1985 | 93 | 0.030 |
Why?
|
Species Specificity | 1 | 2019 | 2478 | 0.030 |
Why?
|
T-Lymphocyte Subsets | 2 | 2001 | 1838 | 0.030 |
Why?
|
Colitis, Collagenous | 1 | 2014 | 26 | 0.030 |
Why?
|
Tenascin | 1 | 2014 | 59 | 0.030 |
Why?
|
Genetic Association Studies | 2 | 2015 | 2703 | 0.030 |
Why?
|
Muscular Diseases | 2 | 1992 | 556 | 0.030 |
Why?
|
Saimiri | 2 | 1985 | 330 | 0.030 |
Why?
|
Lipopolysaccharides | 2 | 2013 | 2216 | 0.030 |
Why?
|
In Situ Hybridization | 2 | 2015 | 1950 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2010 | 15076 | 0.030 |
Why?
|
Pregnancy | 3 | 2017 | 29144 | 0.030 |
Why?
|
RNA, Viral | 2 | 1994 | 2902 | 0.030 |
Why?
|
Immunologic Memory | 1 | 2000 | 1348 | 0.030 |
Why?
|
Tumor Burden | 1 | 2019 | 1915 | 0.030 |
Why?
|
Risk Factors | 7 | 2017 | 72290 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2016 | 3597 | 0.030 |
Why?
|
Down-Regulation | 2 | 2013 | 3002 | 0.030 |
Why?
|
Immunoglobulin M | 2 | 2010 | 1537 | 0.030 |
Why?
|
Pancreatitis | 2 | 1992 | 1092 | 0.030 |
Why?
|
Biofeedback, Psychology | 1 | 1994 | 115 | 0.030 |
Why?
|
Biological Availability | 2 | 2004 | 397 | 0.030 |
Why?
|
Patient Care | 1 | 1999 | 640 | 0.030 |
Why?
|
Brain | 1 | 2020 | 26385 | 0.030 |
Why?
|
Polymorphism, Genetic | 1 | 2003 | 4328 | 0.030 |
Why?
|
Leukemia | 1 | 2001 | 1511 | 0.030 |
Why?
|
Antigens, CD19 | 1 | 2015 | 380 | 0.030 |
Why?
|
Macaca fascicularis | 2 | 1985 | 915 | 0.030 |
Why?
|
Lysine | 1 | 1997 | 1007 | 0.030 |
Why?
|
Platelet Count | 1 | 2015 | 781 | 0.030 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2007 | 3923 | 0.030 |
Why?
|
Ligands | 1 | 1999 | 3282 | 0.030 |
Why?
|
Drug Resistance | 1 | 1998 | 1609 | 0.030 |
Why?
|
Homozygote | 1 | 2017 | 1785 | 0.030 |
Why?
|
RNA-Binding Proteins | 1 | 2021 | 1903 | 0.030 |
Why?
|
Sialorrhea | 1 | 1992 | 25 | 0.030 |
Why?
|
Patient Selection | 2 | 2017 | 4215 | 0.030 |
Why?
|
Bottle Feeding | 1 | 1992 | 66 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2019 | 35421 | 0.030 |
Why?
|
Nausea | 1 | 1995 | 673 | 0.030 |
Why?
|
Pain | 1 | 1987 | 4986 | 0.030 |
Why?
|
Transplantation, Heterotopic | 1 | 1992 | 175 | 0.030 |
Why?
|
Xylose | 1 | 1991 | 28 | 0.030 |
Why?
|
SEER Program | 1 | 2017 | 1508 | 0.030 |
Why?
|
Vomiting | 1 | 1995 | 636 | 0.030 |
Why?
|
Glutamic Acid | 1 | 1997 | 1169 | 0.030 |
Why?
|
Skin Neoplasms | 2 | 2002 | 5686 | 0.030 |
Why?
|
Kinetics | 1 | 1999 | 6473 | 0.030 |
Why?
|
Triglycerides | 1 | 1999 | 2454 | 0.030 |
Why?
|
RNA Splice Sites | 1 | 2012 | 209 | 0.030 |
Why?
|
Immunocompromised Host | 1 | 2017 | 847 | 0.020 |
Why?
|
Workflow | 1 | 2016 | 847 | 0.020 |
Why?
|
Receptor, erbB-2 | 1 | 2021 | 2416 | 0.020 |
Why?
|
Receptors, CCR10 | 1 | 2010 | 10 | 0.020 |
Why?
|
Immunoglobulin J-Chains | 1 | 2010 | 27 | 0.020 |
Why?
|
Dental Prophylaxis | 1 | 2010 | 26 | 0.020 |
Why?
|
Lipoxygenase Inhibitors | 1 | 1991 | 94 | 0.020 |
Why?
|
Body Height | 2 | 2008 | 1577 | 0.020 |
Why?
|
Lung Diseases | 1 | 1981 | 1886 | 0.020 |
Why?
|
Receptors, CCR | 1 | 2010 | 38 | 0.020 |
Why?
|
Jejunum | 2 | 1990 | 480 | 0.020 |
Why?
|
Protein Stability | 1 | 2012 | 557 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2011 | 25043 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2002 | 8301 | 0.020 |
Why?
|
Heterozygote | 1 | 1997 | 2804 | 0.020 |
Why?
|
Rats | 2 | 2010 | 24260 | 0.020 |
Why?
|
Porins | 1 | 2010 | 81 | 0.020 |
Why?
|
Gallbladder | 1 | 1992 | 302 | 0.020 |
Why?
|
Food, Fortified | 1 | 1992 | 191 | 0.020 |
Why?
|
Reimbursement Mechanisms | 1 | 2016 | 670 | 0.020 |
Why?
|
Pressure | 1 | 1994 | 1203 | 0.020 |
Why?
|
Transplantation, Isogeneic | 1 | 2010 | 257 | 0.020 |
Why?
|
Bacteria | 1 | 2021 | 2114 | 0.020 |
Why?
|
Prolactin | 1 | 1992 | 669 | 0.020 |
Why?
|
RNA, Messenger | 3 | 2013 | 13033 | 0.020 |
Why?
|
Metronidazole | 1 | 1991 | 217 | 0.020 |
Why?
|
Palatine Tonsil | 1 | 2010 | 193 | 0.020 |
Why?
|
History, 20th Century | 1 | 2018 | 2740 | 0.020 |
Why?
|
Cholecystectomy | 1 | 1992 | 395 | 0.020 |
Why?
|
Genes, Homeobox | 1 | 1991 | 286 | 0.020 |
Why?
|
Cyclosporine | 1 | 2012 | 786 | 0.020 |
Why?
|
Promoter Regions, Genetic | 2 | 2013 | 5867 | 0.020 |
Why?
|
Cross-Over Studies | 2 | 2006 | 2029 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2001 | 11366 | 0.020 |
Why?
|
Chemokines, CC | 1 | 2010 | 291 | 0.020 |
Why?
|
Toll-Like Receptors | 1 | 2013 | 592 | 0.020 |
Why?
|
Autoradiography | 1 | 1990 | 745 | 0.020 |
Why?
|
Recombinant Proteins | 2 | 2010 | 6622 | 0.020 |
Why?
|
Gene Expression | 2 | 2014 | 7799 | 0.020 |
Why?
|
Lymphocyte Culture Test, Mixed | 4 | 1983 | 517 | 0.020 |
Why?
|
Intestinal Fistula | 1 | 2010 | 140 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2021 | 3586 | 0.020 |
Why?
|
Thalidomide | 1 | 2014 | 890 | 0.020 |
Why?
|
Tacrolimus | 1 | 2012 | 743 | 0.020 |
Why?
|
Leukocyte Migration-Inhibitory Factors | 3 | 1983 | 12 | 0.020 |
Why?
|
Lung | 1 | 1987 | 9856 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2017 | 16689 | 0.020 |
Why?
|
Macrophages | 1 | 1983 | 5655 | 0.020 |
Why?
|
alpha 1-Antitrypsin | 1 | 1989 | 164 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2017 | 3479 | 0.020 |
Why?
|
Reproducibility of Results | 3 | 2019 | 19905 | 0.020 |
Why?
|
Rats, Inbred Lew | 1 | 2010 | 1162 | 0.020 |
Why?
|
Radiography, Interventional | 1 | 2016 | 1095 | 0.020 |
Why?
|
Physician-Patient Relations | 1 | 2002 | 3229 | 0.020 |
Why?
|
Ampulla of Vater | 1 | 1989 | 141 | 0.020 |
Why?
|
Gene Frequency | 1 | 2015 | 3588 | 0.020 |
Why?
|
Macaca mulatta | 2 | 1985 | 2375 | 0.020 |
Why?
|
Anthropometry | 1 | 1993 | 1350 | 0.020 |
Why?
|
Hirschsprung Disease | 1 | 1990 | 155 | 0.020 |
Why?
|
Immunoglobulins | 1 | 1991 | 881 | 0.020 |
Why?
|
Drug Therapy, Combination | 2 | 2009 | 6489 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2000 | 4386 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2012 | 1850 | 0.020 |
Why?
|
Muscle, Smooth | 1 | 1992 | 934 | 0.020 |
Why?
|
Ultrasonography, Interventional | 1 | 2016 | 1486 | 0.020 |
Why?
|
Organ Preservation | 1 | 2010 | 331 | 0.020 |
Why?
|
Endocrine System | 1 | 2008 | 113 | 0.020 |
Why?
|
Prevalence | 1 | 2004 | 15226 | 0.020 |
Why?
|
Pyloric Antrum | 1 | 1987 | 69 | 0.020 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2019 | 2737 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2013 | 944 | 0.020 |
Why?
|
HIV Seropositivity | 1 | 1993 | 971 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 1991 | 2645 | 0.020 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 1994 | 1130 | 0.020 |
Why?
|
Lactose | 1 | 1987 | 95 | 0.020 |
Why?
|
Lymphocytes | 2 | 1987 | 2617 | 0.020 |
Why?
|
Neutropenia | 1 | 1992 | 895 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 1997 | 6171 | 0.020 |
Why?
|
Linear Models | 1 | 2017 | 5952 | 0.020 |
Why?
|
Intestinal Neoplasms | 1 | 1989 | 319 | 0.020 |
Why?
|
Hydrogen | 1 | 1987 | 164 | 0.020 |
Why?
|
Hematocrit | 1 | 2008 | 636 | 0.020 |
Why?
|
Atrophy | 1 | 1991 | 1583 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 1999 | 2291 | 0.020 |
Why?
|
Phytohemagglutinins | 2 | 1983 | 170 | 0.020 |
Why?
|
Gases | 1 | 1987 | 197 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 1998 | 8642 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2010 | 2327 | 0.020 |
Why?
|
Embryonic and Fetal Development | 1 | 1987 | 438 | 0.020 |
Why?
|
Equipment Safety | 1 | 2006 | 264 | 0.020 |
Why?
|
Analysis of Variance | 1 | 1994 | 6365 | 0.020 |
Why?
|
Logistic Models | 2 | 2015 | 13408 | 0.020 |
Why?
|
Curriculum | 1 | 1999 | 3605 | 0.020 |
Why?
|
Microcirculation | 1 | 2010 | 1286 | 0.020 |
Why?
|
Chromatography, DEAE-Cellulose | 1 | 1985 | 87 | 0.020 |
Why?
|
Hypertrophy | 1 | 1987 | 569 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 1989 | 2505 | 0.020 |
Why?
|
Genes | 1 | 1989 | 1893 | 0.020 |
Why?
|
Infusions, Parenteral | 1 | 2005 | 419 | 0.020 |
Why?
|
Thymus Gland | 1 | 1990 | 1267 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2009 | 578 | 0.020 |
Why?
|
Child Development | 1 | 1996 | 2223 | 0.020 |
Why?
|
Filariasis | 1 | 1984 | 28 | 0.020 |
Why?
|
Nutrition Policy | 1 | 2008 | 488 | 0.020 |
Why?
|
Acute Disease | 2 | 2012 | 7149 | 0.020 |
Why?
|
Interleukin-4 | 1 | 2008 | 1147 | 0.020 |
Why?
|
Transaminases | 1 | 1984 | 199 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2015 | 4803 | 0.010 |
Why?
|
Linkage Disequilibrium | 1 | 2009 | 1997 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2012 | 4186 | 0.010 |
Why?
|
Esterases | 1 | 1983 | 95 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2015 | 3462 | 0.010 |
Why?
|
Capsules | 1 | 2004 | 196 | 0.010 |
Why?
|
Metabolic Clearance Rate | 1 | 2004 | 380 | 0.010 |
Why?
|
Spleen | 1 | 1990 | 2362 | 0.010 |
Why?
|
DNA, Viral | 1 | 1990 | 2225 | 0.010 |
Why?
|
Reference Values | 1 | 2011 | 4982 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2022 | 12261 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2016 | 3528 | 0.010 |
Why?
|
Peroxidases | 1 | 1983 | 138 | 0.010 |
Why?
|
Intubation | 1 | 2003 | 141 | 0.010 |
Why?
|
Developmental Disabilities | 1 | 1992 | 1456 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2021 | 5442 | 0.010 |
Why?
|
Respiratory Function Tests | 1 | 1987 | 1616 | 0.010 |
Why?
|
Signal Transduction | 2 | 2021 | 23403 | 0.010 |
Why?
|
Zoonoses | 1 | 1984 | 185 | 0.010 |
Why?
|
Computational Biology | 1 | 2015 | 3521 | 0.010 |
Why?
|
Immunotherapy | 1 | 1998 | 4445 | 0.010 |
Why?
|
Receptors, Complement | 1 | 1983 | 264 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 2012 | 2278 | 0.010 |
Why?
|
Dyspnea | 1 | 2010 | 1303 | 0.010 |
Why?
|
Protein Binding | 1 | 1994 | 9386 | 0.010 |
Why?
|
Administration, Intranasal | 1 | 2003 | 446 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 1998 | 7913 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 1991 | 2540 | 0.010 |
Why?
|
Leukocytes | 1 | 2010 | 2043 | 0.010 |
Why?
|
Guinea Pigs | 1 | 1983 | 1386 | 0.010 |
Why?
|
Adenocarcinoma | 2 | 1989 | 6364 | 0.010 |
Why?
|
Family | 1 | 2012 | 3147 | 0.010 |
Why?
|
Catheterization | 1 | 1987 | 1470 | 0.010 |
Why?
|
Antigens, T-Independent | 1 | 2000 | 21 | 0.010 |
Why?
|
Probability | 1 | 2006 | 2505 | 0.010 |
Why?
|
Diet | 2 | 2017 | 7939 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2014 | 3647 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2006 | 2886 | 0.010 |
Why?
|
Deglutition Disorders | 1 | 1986 | 605 | 0.010 |
Why?
|
Muscles | 3 | 1992 | 1614 | 0.010 |
Why?
|
Liver | 3 | 1992 | 7474 | 0.010 |
Why?
|
Radionuclide Imaging | 2 | 2002 | 2031 | 0.010 |
Why?
|
Amino Acid Metabolism, Inborn Errors | 1 | 1983 | 255 | 0.010 |
Why?
|
New England | 1 | 2003 | 1022 | 0.010 |
Why?
|
Hypersensitivity, Delayed | 2 | 1998 | 484 | 0.010 |
Why?
|
Pulmonary Alveoli | 1 | 1983 | 675 | 0.010 |
Why?
|
Pneumonia, Aspiration | 1 | 1981 | 145 | 0.010 |
Why?
|
Digestive System Diseases | 1 | 2002 | 147 | 0.010 |
Why?
|
Graft Survival | 1 | 1991 | 3737 | 0.010 |
Why?
|
Nutritional Status | 1 | 2008 | 1609 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2004 | 1572 | 0.010 |
Why?
|
HLA-D Antigens | 1 | 2000 | 134 | 0.010 |
Why?
|
Fetal Blood | 2 | 1983 | 1318 | 0.010 |
Why?
|
Hemodynamics | 1 | 2010 | 4199 | 0.010 |
Why?
|
Demography | 1 | 2005 | 1656 | 0.010 |
Why?
|
Receptors, Fc | 1 | 1983 | 541 | 0.010 |
Why?
|
Intraoperative Complications | 1 | 2006 | 1198 | 0.010 |
Why?
|
Quality Control | 1 | 2002 | 841 | 0.010 |
Why?
|
Asia | 1 | 2001 | 610 | 0.010 |
Why?
|
Esophageal Neoplasms | 1 | 1989 | 1583 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 1985 | 1375 | 0.010 |
Why?
|
Phantoms, Imaging | 1 | 2007 | 2480 | 0.010 |
Why?
|
Staining and Labeling | 1 | 1983 | 1100 | 0.010 |
Why?
|
Anemia | 1 | 2008 | 1506 | 0.010 |
Why?
|
Epithelial Cells | 1 | 1991 | 3690 | 0.010 |
Why?
|
Inhalation | 1 | 1979 | 143 | 0.010 |
Why?
|
Tyrosine | 1 | 1983 | 1461 | 0.010 |
Why?
|
Cytodiagnosis | 1 | 1982 | 435 | 0.010 |
Why?
|
Skin Pigmentation | 1 | 2000 | 282 | 0.010 |
Why?
|
Equipment Design | 1 | 2006 | 3582 | 0.010 |
Why?
|
Antibodies | 1 | 2006 | 2460 | 0.010 |
Why?
|
Laparoscopy | 1 | 2010 | 2151 | 0.010 |
Why?
|
Data Collection | 1 | 2007 | 3341 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2010 | 3479 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2008 | 5974 | 0.010 |
Why?
|
Lymphedema | 1 | 1984 | 534 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2007 | 2585 | 0.010 |
Why?
|
Bacterial Infections | 1 | 1985 | 1401 | 0.010 |
Why?
|
Receptors, Immunologic | 1 | 1983 | 1423 | 0.010 |
Why?
|
Lead | 1 | 2002 | 852 | 0.010 |
Why?
|
Length of Stay | 1 | 2010 | 6309 | 0.010 |
Why?
|
Interferons | 1 | 1980 | 706 | 0.010 |
Why?
|
Cell Count | 1 | 2000 | 1856 | 0.010 |
Why?
|
Radiography | 2 | 1984 | 7023 | 0.010 |
Why?
|
Bone Density | 1 | 2008 | 3468 | 0.010 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2002 | 1320 | 0.010 |
Why?
|
New York | 1 | 1977 | 886 | 0.010 |
Why?
|
Comorbidity | 1 | 2009 | 10388 | 0.010 |
Why?
|
Pharynx | 1 | 1977 | 413 | 0.010 |
Why?
|
Artifacts | 1 | 2002 | 1904 | 0.010 |
Why?
|
Breast Feeding | 1 | 2002 | 1338 | 0.010 |
Why?
|
Immunity, Cellular | 1 | 1979 | 1607 | 0.010 |
Why?
|
Health Status Indicators | 1 | 1999 | 969 | 0.010 |
Why?
|
Nose | 1 | 1977 | 509 | 0.010 |
Why?
|
Base Sequence | 2 | 1997 | 12797 | 0.010 |
Why?
|
Canada | 1 | 1998 | 2065 | 0.010 |
Why?
|
Respiration | 1 | 1979 | 1653 | 0.010 |
Why?
|
Pilot Projects | 1 | 2005 | 8324 | 0.010 |
Why?
|
Amylases | 1 | 1992 | 173 | 0.010 |
Why?
|
Disease Progression | 1 | 2008 | 13284 | 0.010 |
Why?
|
Killer Cells, Natural | 1 | 2000 | 2133 | 0.010 |
Why?
|
Phenotype | 1 | 2009 | 16365 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 1997 | 18111 | 0.010 |
Why?
|
Mucous Membrane | 1 | 1994 | 673 | 0.010 |
Why?
|
Body Weight | 1 | 2002 | 4669 | 0.010 |
Why?
|
L-Lactate Dehydrogenase | 1 | 1992 | 424 | 0.010 |
Why?
|
Aspartate Aminotransferases | 1 | 1992 | 418 | 0.010 |
Why?
|
Models, Biological | 1 | 1987 | 9583 | 0.010 |
Why?
|
DNA Probes | 1 | 1991 | 560 | 0.010 |
Why?
|
International Cooperation | 1 | 1996 | 1420 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1991 | 1085 | 0.010 |
Why?
|
Lipase | 1 | 1992 | 314 | 0.010 |
Why?
|
Dendritic Cells | 1 | 2000 | 2725 | 0.010 |
Why?
|
Drug Evaluation | 1 | 1990 | 647 | 0.010 |
Why?
|
Alanine Transaminase | 1 | 1992 | 592 | 0.010 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 1991 | 906 | 0.010 |
Why?
|
Immunoblotting | 1 | 1992 | 1682 | 0.010 |
Why?
|
Opportunistic Infections | 1 | 1992 | 389 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 1976 | 2513 | 0.010 |
Why?
|
Alkaline Phosphatase | 1 | 1992 | 865 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 1976 | 2765 | 0.000 |
Why?
|
Gene Library | 1 | 1991 | 1074 | 0.000 |
Why?
|
Survival Analysis | 1 | 2000 | 10252 | 0.000 |
Why?
|
Pancreatic Ducts | 1 | 1989 | 328 | 0.000 |
Why?
|
Esophageal Diseases | 1 | 1988 | 166 | 0.000 |
Why?
|
Stomach Diseases | 1 | 1988 | 134 | 0.000 |
Why?
|
Mouth Diseases | 1 | 1988 | 241 | 0.000 |
Why?
|
Cloning, Molecular | 1 | 1991 | 4320 | 0.000 |
Why?
|
Fructose-Bisphosphate Aldolase | 1 | 1984 | 52 | 0.000 |
Why?
|
Malta | 1 | 1984 | 6 | 0.000 |
Why?
|
Libya | 1 | 1984 | 9 | 0.000 |
Why?
|
Brugia | 1 | 1984 | 24 | 0.000 |
Why?
|
Oklahoma | 1 | 1984 | 37 | 0.000 |
Why?
|
Mitochondria, Liver | 1 | 1984 | 187 | 0.000 |
Why?
|
Boston | 1 | 1977 | 9313 | 0.000 |
Why?
|
Drosophila | 1 | 1991 | 1491 | 0.000 |
Why?
|
alpha-Fetoproteins | 1 | 1983 | 224 | 0.000 |
Why?
|
Creatine Kinase | 1 | 1984 | 694 | 0.000 |
Why?
|
Asthma | 1 | 1981 | 6011 | 0.000 |
Why?
|
Liver Cirrhosis | 1 | 1992 | 1863 | 0.000 |
Why?
|
Newcastle disease virus | 1 | 1980 | 23 | 0.000 |
Why?
|
Methionine | 1 | 1983 | 590 | 0.000 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 1976 | 3523 | 0.000 |
Why?
|
Rosette Formation | 1 | 1979 | 153 | 0.000 |
Why?
|
Macrophage Migration-Inhibitory Factors | 1 | 1979 | 108 | 0.000 |
Why?
|
Technetium | 1 | 1979 | 334 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1991 | 13815 | 0.000 |
Why?
|
Barium Sulfate | 1 | 1979 | 180 | 0.000 |
Why?
|
Methods | 1 | 1979 | 1129 | 0.000 |
Why?
|
Travel | 1 | 1984 | 788 | 0.000 |
Why?
|
Graft vs Host Reaction | 1 | 1976 | 104 | 0.000 |
Why?
|
Respiratory System | 1 | 1979 | 557 | 0.000 |
Why?
|
Liver Function Tests | 1 | 1976 | 528 | 0.000 |
Why?
|
Cell Line | 1 | 1989 | 15997 | 0.000 |
Why?
|
Cell Differentiation | 1 | 1989 | 11483 | 0.000 |
Why?
|
Transcription Factors | 1 | 1991 | 12208 | 0.000 |
Why?
|
HLA Antigens | 1 | 1976 | 1381 | 0.000 |
Why?
|
Transplantation, Homologous | 1 | 1976 | 4776 | 0.000 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 1979 | 2988 | 0.000 |
Why?
|